Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |